-
5-{N-[3-(N-{3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl}acetamido)-2-hydroxypropyl]acetamido}-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
-
ChemBase ID:
1118
-
Molecular Formular:
C35H44I6N6O15
-
Molecular Mass:
1550.18188
-
Monoisotopic Mass:
1549.71330274
-
SMILES and InChIs
SMILES:
Ic1c(N(CC(O)CN(c2c(I)c(c(I)c(c2I)C(=O)NCC(O)CO)C(=O)NCC(O)CO)C(=O)C)C(=O)C)c(I)c(c(I)c1C(=O)NCC(O)CO)C(=O)NCC(O)CO
Canonical SMILES:
OCC(CNC(=O)c1c(I)c(N(C(=O)C)CC(CN(c2c(I)c(C(=O)NCC(CO)O)c(c(c2I)C(=O)NCC(CO)O)I)C(=O)C)O)c(c(c1I)C(=O)NCC(CO)O)I)O
InChI:
InChI=1S/C35H44I6N6O15/c1-13(52)46(30-26(38)20(32(59)42-3-15(54)9-48)24(36)21(27(30)39)33(60)43-4-16(55)10-49)7-19(58)8-47(14(2)53)31-28(40)22(34(61)44-5-17(56)11-50)25(37)23(29(31)41)35(62)45-6-18(57)12-51/h15-19,48-51,54-58H,3-12H2,1-2H3,(H,42,59)(H,43,60)(H,44,61)(H,45,62)
InChIKey:
NBQNWMBBSKPBAY-UHFFFAOYSA-N
-
Cite this record
CBID:1118 http://www.chembase.cn/molecule-1118.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
5-{N-[3-(N-{3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl}acetamido)-2-hydroxypropyl]acetamido}-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
|
|
|
IUPAC Traditional name
|
|
Brand Name
|
Visipaque
|
Visipaque 270
|
Visipaque 320
|
|
|
Synonyms
|
Indixanol
|
Iodixanolum
|
Iodixanol
|
5,5'-[(2-Hydroxy-1,3-propanediyl)bis(acetylimino)]bis[N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
|
2-5410-3A
|
OptiPrep
|
Visipaque
|
Iodixanol solution
|
OptiPrep™ Density Gradient Medium
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
11.433949
|
H Acceptors
|
15
|
H Donor
|
13
|
LogD (pH = 5.5)
|
-2.0626314
|
LogD (pH = 7.4)
|
-2.0626664
|
Log P
|
-2.062631
|
Molar Refractivity
|
277.1619 cm3
|
Polarizability
|
107.42674 Å3
|
Polar Surface Area
|
339.09 Å2
|
Rotatable Bonds
|
22
|
Lipinski's Rule of Five
|
false
|
Log P
|
-2.91
|
LOG S
|
-3.92
|
Solubility (Water)
|
1.85e-01 g/l
|
DETAILS
DETAILS
DrugBank
Sigma Aldrich
TRC
DrugBank -
DB01249
|
Item |
Information |
Drug Groups
|
approved |
Description
|
Iodixanol is a nonionic hydrophilic compound commonly used as a contrast agent during coronary angiography, particularly in individuals with renal dysfunction, as it is believed to be less toxic to the kidneys than most other intravascular contrast agents. |
Indication |
Iodixanol is a contrast agent during coronary angiography. |
Pharmacology |
Iodixanol is a contrast agent commonly used during coronary angiography, particularly in individuals with renal dysfunction, as it is believed to be less toxic to the kidneys than most other intravascular contrast agents. It is an iso-osmolar contrast agent, with an osmolality of 290 mOsm/kg H20, the same as blood. |
Toxicity |
Non-ionic radiocontrast agents like iodixanol are cytotoxic to renal cells. The toxic effects include apoptosis, cellular energy failure, disruption of calcium homeostasis, and disturbance of tubular cell polarity, and are thought to be linked to oxidative stress. |
Affected Organisms |
• |
Humans and other mammals |
|
Biotransformation |
Excreted unchanged |
Half Life |
2.1 hours. In patients with significantly impaired renal function (mean creatinine clearance rate, 9.91 [± 3.58] mL per minute), the plasma half-life is increased to 23 hours. |
Protein Binding |
Negligible |
Elimination |
In adults, approximately 97% of the injected dose of iodixanol is excreted unchanged in urine within 24 hours, with less than 2% excreted in feces within five days post-injection. |
Distribution |
* 0.26 L/kg |
References |
• |
Spencer CM, Goa KL: Iodixanol. A review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as an x-ray contrast medium. Drugs. 1996 Dec;52(6):899-927.
[Pubmed]
|
• |
McCullough PA: Renal safety of iodixanol. Expert Rev Cardiovasc Ther. 2006 Sep;4(5):655-61.
[Pubmed]
|
|
External Links |
|
|
Sigma Aldrich -
D1556
|
Frequently Asked Questions Live Chat and Frequently Asked Questions are available for this Product. Application Density gradient suitable for isolation of cells and cell organelles, virus purification, and isolation of lipoproteins and macromolecules. Other Notes 60% (w/v) solution of iodixanol in water (sterile). 法律信息 OptiPrep is a trademark of Axis-Shield PoC AS |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • McCullough PA: Renal safety of iodixanol. Expert Rev Cardiovasc Ther. 2006 Sep;4(5):655-61. Pubmed
- • Spencer CM, Goa KL: Iodixanol. A review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as an x-ray contrast medium. Drugs. 1996 Dec;52(6):899-927. Pubmed
- • Svaland, M.G., et al.: Invest. Radiol., 27, 130 (1992)
- • Palmers, Y., et al.: Eur. J. Radiol., 17, 203 (1992)
- • Conroy, R.M., et al.: Clin. Radiol., 49, 337 (1992)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent